Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort

American Journal of Kidney Diseases

Volumn 73, Issue 6, 2019, Pages 765-776

  Naylor, Kyla L ^a,b   Kim, S Joseph ^a,c   McArthur, Eric ^a   Garg, Amit X ^a,d   McCallum, Megan K ^a   Knoll, Gregory A ^e,f  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

advance care planning; all cause mortality; cancer; death; end stage kidney disease (ESKD); Maintenance dialysis; mortality burden; prognosis; survival

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; BREAST CANCER; CANADA; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE BURDEN; END STAGE RENAL DISEASE; FEMALE; GENDER; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LUNG CANCER; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; PANCREAS CANCER; POPULATION RESEARCH; PROGNOSTIC ASSESSMENT; SURVIVAL RATE; YOUNG ADULT; AGE; BREAST TUMOR; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COLORECTAL TUMOR; COMPARATIVE STUDY; FACTUAL DATABASE; HEMODIALYSIS; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY TUMOR; LUNG TUMOR; MORTALITY; NEOPLASM; ONTARIO; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEX FACTOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANADA; CAUSE OF DEATH; COHORT STUDIES; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; ONTARIO; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 85064485782     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2018.12.011     Document Type: Article

References (39)

1. Liyanage, T., Ninomiya, T., Jha, V., et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:9981 (2015), 1975–1982.
2. Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012. 2014, CIHI, Ottawa, ON, Canada.
3. Wachterman, M.W., Marcantonio, E.R., Davis, R.B., et al. Relationship between the prognostic expectations of seriously ill patients undergoing hemodialysis and their nephrologists. JAMA Intern Med 173:13 (2013), 1206–1214.
4. Institute of Medicine of the National Acadamies. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. 2008, IOM, Washington, DC.
5. Stegall, M.D., Morris, R.E., Alloway, R.R., Mannon, R.B., Developing new immunosuppression for the next generation of transplant recipients: the path forward. Am J Transplant 16:4 (2016), 1094–1101.
6. Covic, A., Gusbeth-Tatomir, P., Goldsmith, D., Negative outcome studies in end-stage renal disease: how dark are the storm clouds?. Nephrol Dial Transplant 23:1 (2008), 56–61.
7. Saran R, Li Y, Robinson B, et al. US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;67(3)(suppl 1):S1-S434.
8. Kiberd, B., Clase, C.M., Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol 13:6 (2002), 1635–1644.
9. Benchimol, E.I., Smeeth, L., Guttmann, A., et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement. PLoS Med, 12(10), 2015, e1001885.
10. Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2004 to 2013. 2015, CIHI, Ottawa, ON, Canada.
11. Robles, S.C., Marrett, L.D., Aileen Clarke, E., Risch, H.A., An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41:5 (1988), 495–501.
12. Ontario Ministry of Finance. Ontario Population Projections Update 2012-2036. 2013, Canada: Government of Ontario, Toronto, ON.
13. A Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics. 2015, Canadian Cancer Society, Toronto, ON, Canada.
14. Quinn, R.R., Laupacis, A., Austin, P.C., et al. Using administrative datasets to study outcomes in dialysis patients: a validation study. Med Care 48:8 (2010), 745–750.
15. Iron, K., Sykora, K., Manuel, D.G., Living and Dying in Ontario: An Opportunity for Improved Health Information. ICES Investigative Report. 2008, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
16. Kleinbaum, D.G., Klein, M., Extension of the Cox proportional hazards model for time-dependent variables. Statistics for Biology and Health: Survival Analysis A Self-Learning Text, 2nd ed., 2005, Springer Science+Business Media, Inc, New York, NY, 211–256.
17. Szczech, L.A., Coladonato, J.A., Owen, W.F., Study designs and their potential influence on conclusions. Semin Dial 15:3 (2002), 207–211.
18. Lazenby, S., Edwards, A., Samuriwo, R., Riley, S., Murray, M.A., Carson-Stevens, A., End-of-life care decisions for haemodialysis patients – ‘We only tend to have that discussion with them when they start deteriorating. Health Expect 20:2 (2017), 260–273.
19. Kurella Tamura, M., Cohen, L.M., Should there be an expanded role for palliative care in end-stage renal disease?. Curr Opin Nephrol Hypertens 19:6 (2010), 556–560.
20. Davison, S.N., End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol 5:2 (2010), 195–204.
21. Holley, J.L., Hines, S.C., Glover, J.J., Babrow, A.S., Badzek, L.A., Moss, A.H., Failure of advance care planning to elicit patients’ preferences for withdrawal from dialysis. Am J Kidney Dis 33:4 (1999), 688–693.
22. Singer, P.A., Martin, D.K., Lavery, J.V., Thiel, E.C., Kelner, M., Mendelssohn, D.C., Reconceptualizing advance care planning from the patient's perspective. Arch Intern Med 158:8 (1998), 879–884.
23. Davison, S.N., Kromm, S.K., Currie, G.R., Patient and health professional preferences for organ allocation and procurement, end-of-life care and organization of care for patients with chronic kidney disease using a discrete choice experiment. Nephrol Dial Transplant 25:7 (2010), 2334–2341.
24. Autier, P., Boniol, M., LaVecchia, C., et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ, 341, 2010, c4480.
25. Cancer Research UK. International cancer benchmarking partnership. http://www.cancerresearchuk.org/cancer-info/spotcancerearly/ICBP/. (Accessed 30 June 2017)
26. Mokdad, A.H., Dwyer-Lindgren, L., Fitzmaurice, C., et al. Trends and patterns of disparities in cancer mortality among US counties, 1980-2014. JAMA 317:4 (2017), 388–406.
27. Canadian Institute for Health Information (CIHI). CORR annual statistics. https://www.cihi.ca/en/corr-annual-statistics-2017, 2017. (Accessed 1 October 2018)
28. Canadian Cancer Society. Canadian Cancer Statistics media fact sheet. http://www.cancer.ca/en/about-us/for-media/media-releases/national/2017/canadian-cancer-statistics-media-fact-sheet/?region=on. (Accessed 1 October 2018)
29. Piccirillo, J.F., Vlahiotis, A., Barrett, L.B., Flood, K.L., Spitznagel, E.L., Steyerberg, E.W., The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67:2 (2008), 124–132.
30. Strippoli, G.F.M., The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol 15:2 (2004), 411–419.
31. Inrig, J.K., Califf, R.M., Tasneem, A., et al. The landscape of clinical trials in nephrology: a systematic review of clinicaltrials.gov. Am J Kidney Dis 63:5 (2014), 771–780.
32. Bryan, L., Ibrahim, T., Zent, R., Fischer, M.J., The kidney research predicament. J Am Soc Nephrol 25:5 (2014), 898–903.
33. National Institutes of Health. Estimates of funding for various research, condition, and disease categories. https://report.nih.gov/categorical_spending.aspx. (Accessed 3 July 2018)
34. Rana, A., Gruessner, A., Agopian, V.G., et al. Survival benefit of solid-organ transplant in the United States. JAMA Surg 150:3 (2015), 252–259.
35. US Renal Data System. Chapter 5: Mortality. https://www.usrds.org/2017/view/v2_05.aspx. Accessed July 3, 2018.
36. Foley, R.N., Li, S., Liu, J., Gilbertson, D.T., Chen, S.-C., Collins, A.J., The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 16:1 (2005), 210–218.
37. Tentori, F., Blayney, M.J., Albert, J.M., et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52:3 (2008), 519–530.
38. Ethier, J., Mendelssohn, D.C., Elder, S.J., et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 23:10 (2008), 3219–3226.
39. Statistics Canada. Immigration and ethnocultural diversity in Canada. https://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.cfm, 2016. (Accessed 8 June 2017)